BioCentury
ARTICLE | Company News

Biocon planning Indian submission for biosimilar Herceptin

October 25, 2013 1:10 AM UTC

Biocon Ltd. (NSE:BIOCON; BSE:BIOCON) said it plans to submit a regulatory application in India for its biosimilar Herceptin trastuzumab "in the near future" after completing an Indian Phase III trial ...